Yanbin Zhou

1.8k citations

50 papers · 1.3k indexed · h-index 22

Impact in

Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Cancer Research top 10%
- Cancer-related molecular mechanisms research

Papers in ⓘ

Molecular Medicine 4
Oncology 19
- Cancer Immunotherapy and Biomarkers 6

Co-authors: Lixia Huang (20 shared papers)Shaoli Li (17 shared papers)Jincui Gu (15 shared papers)Ziying Lin (10 shared papers)Xiaoxian Cui (5 shared papers)Baomo Liu (13 shared papers)Peng Huang (1 shared paper)Michael J. Keating (1 shared paper)
Journals: Journal of Cancer (2 papers)Journal of Thoracic Oncology (2 papers)Oncotarget (2 papers)BMC Cancer (2 papers)PLoS ONE (2 papers)
Partner nations: China United States Canada

In The Last Decade

Yanbin Zhou

47 papers receiving 1.3k citations

Peers

Countries citing papers authored by Yanbin Zhou

Since Specialization

Citations

This map shows the geographic impact of Yanbin Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanbin Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanbin Zhou more than expected).

Fields of papers citing papers by Yanbin Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanbin Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanbin Zhou. The network helps show where Yanbin Zhou may publish in the future.

Co-authors

The 25 scholars most cited alongside Yanbin Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yanbin Zhou Line = papers co-authored together Yanbin Zhou links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Mitochondrial DNA mutations in primary leukemia cells after chemotherapy: clinical significance and therapeutic implications Leukemia ·Jennifer S. Carew, Yanbin Zhou, Maher Albitar, Jennifer Carew, Michael J. Keating, Peng Huang	2003	129
2	Putative Tumor-Suppressive Function of Krüppel-Like Factor 4 in Primary Lung Carcinoma Clinical Cancer Research ·Wenxian Hu, Wayne L. Hofstetter, Hong Li, Yanbin Zhou, Yong He, Abujiang Pataer, Li Wang, Keping Xie, Stephen G. Swisher, Bingliang Fang	2009	107
3	Dissemination and characterization of NDM-1-producing Acinetobacter pittii in an intensive care unit in China Clinical Microbiology and Infection ·Jiyong Yang, Yusheng Chen, Xiaodong Jia, Yanping Luo, Qing Song, Wei Zhao, Y. Wang, H. Liu, Dongyu Zheng, Yi Xia, Rujia Yu, Xiaonan Han, Guo-Qin Jiang, Yanbin Zhou, Wei Zhou, Xiao Hu, Long Liang, Li Han	2012	76
4	Pan-cancer analysis of genomic properties and clinical outcome associated with tumor tertiary lymphoid structure Scientific Reports ·Ziying Lin, Lixia Huang, Shaoli Li, Jincui Gu, Xiaoxian Cui, Yanbin Zhou	2020	74
5	TP53 mutation is associated with a poor clinical outcome for non-small cell lung cancer: Evidence from a meta-analysis Molecular and Clinical Oncology ·Jincui Gu, Yanbin Zhou, Lixia Huang, Weijun Ou, Jian Wu, Shaoli Li, Junwen Xu, Jinlun Feng, Baomo Liu	2016	70
6	Interleukin-32 contributes to invasion and metastasis of primary lung adenocarcinoma via NF-kappaB induced matrix metalloproteinases 2 and 9 expression Cytokine ·Qingli Zeng, Shaoli Li, Yanbin Zhou, Weijun Ou, Xingdong Cai, Longjuan Zhang, Wanling Huang, Lixia Huang, Qinqin Wang	2013	63
7	CTHRC1 induces non-small cell lung cancer (NSCLC) invasion through upregulating MMP-7/MMP-9 BMC Cancer ·Weiling He, Hui Zhang, Yuefeng Wang, Yanbin Zhou, Yifeng Luo, Yongmei Cui, Neng Jiang, Wenting Jiang, Han Wang, Di Xu, Shuhua Li, Zhuo Wang, Yangshan Chen, Yu Sun, Yang Zhang, Hsian‐Rong Tseng, Xuenong Zou, Liantang Wang, Zunfu Ke	2018	54
8	KLF4 inhibition of lung cancer cell invasion by suppression of SPARC expression Cancer Biology & Therapy ·Yanbin Zhou, Wayne L. Hofstetter, Yong He, Wenxian Hu, Abujiang Pataer, Li Wang, Ji Wang, Yihong Zhou, Liping Yu, Bingliang Fang, Stephen G. Swisher	2010	53
9	Notch3 is important for TGF-β-induced epithelial–mesenchymal transition in non-small cell lung cancer bone metastasis by regulating ZEB-1 Cancer Gene Therapy ·L Liu, Xingchao Chen, Ying Wang, Zhipeng Qu, Qiang Lü, Jing Zhao, Xiaolong Yan, H Zhang, Yanbin Zhou	2014	52
10	PTEN loss correlates with T cell exclusion across human cancers BMC Cancer ·Ziying Lin, Lixia Huang, Shao Li Li, Jincui Gu, Xiaoxian Cui, Yanbin Zhou	2021	46
11	A cyclic nano-reactor achieving enhanced photodynamic tumor therapy by reversing multiple resistances Journal of Nanobiotechnology ·Peng Liu, Yanbin Zhou, Xinyi Shi, Yuan Yu, Ying Peng, Surong Hua, Qiange Luo, Jinsong Ding, Yong Li, Wenhu Zhou	2021	36
12	Intraoperative recurrent laryngeal nerve monitoring: a useful method for patients with esophageal cancer Diseases of the Esophagus ·Donglai Zhong, Yanbin Zhou, Yunming Li, Y. Wang, Wei Zhou, Qi Cheng, L. Chen, Jinbo Zhao, Xueyong Li, Xiaolong Yan	2012	35
13	Aberrant Expression of Proteins Involved in Signal Transduction and DNA Repair Pathways in Lung Cancer and Their Association with Clinical Parameters PLoS ONE ·Yong He, Zhen Zhou, Wayne L. Hofstetter, Yanbin Zhou, Wenxian Hu, Chengcheng Guo, Li Wang, Wei Guo, Apar Pataer, Arlene M. Correa, Yiling Lu, Jing Wang, Lixia Diao, Lauren A. Byers, Ignacio I. Wistuba, Jack A. Roth, Stephen G. Swisher, John V. Heymach, Bingliang Fang	2012	33
14	Real-Time Fluorescence Loop Mediated Isothermal Amplification for the Detection of Acinetobacter baumannii PLoS ONE ·Qinqin Wang, Yanbin Zhou, Shaoli Li, Chao Zhuo, Siqi Xu, Lixia Huang, Ling Yang, Kang Liao	2013	32
15	Aptamer density dependent cellular uptake of lipid-capped polymer nanoparticles for polyvalent targeted delivery of vinorelbine to cancer cells RSC Advances ·Zhenbao Liu, Huanzhe Zhao, Ling‐Yun He, Yao Yao, Yanbin Zhou, Jianping Wu, Juewen Liu, Jinsong Ding	2015	30
16	Deciphering Microenvironment of NSCLC based on CD8+ TIL Density and PD-1/PD-L1 Expression Journal of Cancer ·Ziying Lin, Jincui Gu, Xiaoxian Cui, Lixia Huang, Shaoli Li, Jinlun Feng, Baomo Liu, Yanbin Zhou	2018	29
17	The requirement for freshly isolated human colorectal cancer (CRC) cells in isolating CRC stem cells British Journal of Cancer ·Fei Fan, Seth Bellister, Jiahong Lu, X. Ye, DR Boulbes, Federico Tozzi, Eric Sceusi, Scott Kopetz, Feng Tian, Ling Xia, Yanbin Zhou, Rajat Bhattacharya, Lee M. Ellis	2014	28
18	High EGFR copy number predicts benefits from tyrosine kinase inhibitor treatment for non-small cell lung cancer patients with wild-type EGFR Journal of Translational Medicine ·Fang Wang, Sha Fu, Qiong Shao, Yanbin Zhou, Xiao Zhang, Xu Zhang, Cong Xue, Jian-Guang Lin, Li-Xia Huang, Li Zhang, Wei-Min Zhang, Jian-Yong Shao	2013	26
19	Reduced expression of Krüppel-like factor 17 is related to tumor growth and poor prognosis in lung adenocarcinoma Biochemical and Biophysical Research Communications ·Xingdong Cai, Yanbin Zhou, Lixia Huang, Qingli Zeng, Longjuan Zhang, Qinqin Wang, Shaoli Li, Jianqiang Feng, Anjia Han	2012	25
20	Rapamycin as a “One-Stone-Three-Birds” Agent for Cooperatively Enhanced Phototherapies Against Metastatic Breast Cancer ACS Applied Materials & Interfaces ·Peng Liu, Ying Peng, Yanbin Zhou, Xinyi Shi, Qingnian Li, Jinsong Ding, Yang Gao, Wenhu Zhou	2021	23

About Yanbin Zhou

Yanbin Zhou is a scholar working on Molecular Medicine, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology, having authored 50 papers that have together received 1.3k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (12 papers), Cancer Immunotherapy and Biomarkers (6 papers), Cancer-related gene regulation (6 papers), Kruppel-like factors research (5 papers), Lung Cancer Diagnosis and Treatment (5 papers), Immune Cell Function and Interaction (4 papers), Cancer Genomics and Diagnostics (4 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Molecular Medicine (98 citations), Cancer Research (248 citations), Oncology (389 citations), Endocrinology (50 citations) and Molecular Biology (646 citations). Yanbin Zhou has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Lixia Huang, Shaoli Li, Jincui Gu, Ziying Lin, Xiaoxian Cui, Baomo Liu, Peng Huang, Michael J. Keating, Jennifer S. Carew and Maher Albitar. Their work appears in journals such as Journal of Cancer, Journal of Thoracic Oncology, Oncotarget, BMC Cancer and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact